SLC1A2 and Mental deterioration: The reduction of EAAT2 (the human homologue of GLT-1) activity in the early stages of AD has been reported to be correlated with the cognitive decline seen in AD patients29, and studies of heterozygous GLT-1 knockdown mouse models of AD showed exacerbated cognitive decline30, 31.